In three evaluated eyes with classical CNV in patients treated with pegaptanib we noticed after 2 years loss of 6.67 letters , in eleven eyes with occult CNV we established loss of 9.91 letters , and in two eyes with minimally classical CNV the average best-corrected visual acuity ( BCVA ) remained unchanged .